Skip to main content
. 2009 Feb 2;53(4):1567–1573. doi: 10.1128/AAC.01133-08

TABLE 3.

Reciprocal UBTs and AUBTs of doripenem or levofloxacin for 27 individual patients' strainsa

Drug or strain MIC (mg/liter) UBT for indicated collection period (h)
AUBT, 24 h Type of UTI Eradication Genotype
0-4 4-8 8-12 12-16 16-20 20-24
Doripenem
    E. coli 1949821 B-Mb ≤0.015 16,384 4,096 32,768 4,096 32,768 4,096 376,832 s lower cUTI Yes NA
    S. haemolyticus 1949819 B-Mb 1 512 128 1,024 128 2,048 128 15,872 s lower cUTI Yes NA
    E. coli 2297257 B-W 0.03 4,096 2,048 16,384 4,096 32,768 4,096 253,952 as lower cUTI Yes NA
    E. coli 1780063 B-A 0.03 4,096 1,024 4,096 1,024 4,096 1,024 61,440 Pyelonephritis Yes NA
    E. coli 1821385 B-C 0.03 4,096 256 32,768 8,192 8,192 256 215,040 s lower cUTI Yes NA
    E. coli 1889646 B-F 0.03 65,536 32,768 32,768 8,192 65,536 65,536 1,081,344 as lower cUTI MF Unrelated
    E. coli 1889645 B-I 0.03 65,536 32,768 131,072 32,768 65,536 4,096 1,327,104 s lower cUTI Yes NA
    E. coli 1949825 B-K 0.03 16,384 4,096 8,192 2,048 4,096 256 140,288 s lower cUTI MF Closely related
    E. coli 1949826 B-L 0.03 65,536 32,768 131,072 32,768 65,536 16,384 1,376,256 Pyelonephritis Yes NA
    E. coli 2062717 B-P ≤0.015 32,768 1,024 1,024 512 32,768 2,048 280,576 s lower cUTI MF Closely related
    E. faecalis 2215770 B-T 0.25 2,048 512 1,024 512 2,048 512 25,600 s lower cUTI Yes NA
Levofloxacin
    E. faecalis 2297262-10 B-Vb >32 0 0 0 0 0 0 0 as lower cUTI Yes NA
    S. epidermidis 2297262-9 B-Vb >32 1 1 4 2 2 2 48 as lower cUTI Yes NA
    E. faecalis 1780065 B-B 1 16 8 4 4 4 2 152 as lower cUTI MF Indistinguishable
    E. faecalis 2215767-10 B-Sb >32 0 0 1 0 0 0 4 as lower cUTI MF ND
    S. aureus 2215767-9 B-Sb >32 0 0 1 0 0 0 4 as lower cUTI MF ND
    E. coli 1780064 A-X 0.047 1,024 512 256 128 256 128 9,216 Pyelonephritis Yes NA
    E. coli 1655646 A-Y 0.047 2,048 2,048 2,048 1,024 1,024 256 33,792 s lower cUTI Yes NA
    E. coli 1821386 B-D <0.03 2,048 8,192 2,048 4,096 2,048 2,048 81,920 s lower cUTI Yes NA
    E. coli 1949820 B-N 8 0 0 0 0 0 0 0 s lower cUTI MF, CF Indistinguishable
    E. coli 1889647 B-H <0.03 2,048 2,048 512 1,024 512 256 25,600 s lower cUTI Yes NA
    E. coli 2062716 B-R 0.032 1,024 512 512 256 128 64 9,984 s lower cUTI Yes NA
    S. marcescens 2297260 B-U 0.19 512 256 128 128 32 32 4,352 as lower cUTI Yes NA
    P. aeruginosa 1821383 B-E 0.25 32 128 128 128 128 16 2,240 as lower cUTI Yes NA
    P. aeruginosa 2062713 B-Q 0.38 8 4 4 4 4 2 104 s lower cUTI MF Indistinguishable
    S. aureus 1889640 A-Z 0.06 256 128 128 128 64 64 3,072 as lower cUTI Yes NA
    S. epidermidis 1949822 B-J 8 4 4 2 4 2 1 64 as lower cUTI MF Unrelated
a

Eleven patients were treated with doripenem and 16 with levofloxacin. MF, microbiological failure; CF, clinical failure; s, symptomatic; as, asymptomatic.

b

Two strains isolated per patient.